Forus raises $150m Series C at $3bn valuation
Bain Capital Ventures led the financing to expand specialties, care settings and AI-agent capabilities.
Forus raised $150 million in Series C financing at a $3 billion valuation, led by Bain Capital Ventures. Participants included Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures and SV Angel.
The company will expand into additional specialties and care settings, extend AI agents across the treatment-access process and invest in its team. Forus reports use by providers in all 50 states and work with nine of the 15 largest global biopharma companies.
Use of funds
Expand into all specialties and care settings
Extend AI agents across the path to treatment
Invest in the team